Andra AP fonden Invests $18.80 Million in CME Group Inc. $CME

Andra AP fonden bought a new stake in CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 68,200 shares of the financial services provider’s stock, valued at approximately $18,797,000.

Several other hedge funds have also added to or reduced their stakes in the company. Webster Bank N. A. increased its position in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after buying an additional 60 shares during the period. Highline Wealth Partners LLC increased its position in CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 43 shares during the period. Cornerstone Planning Group LLC increased its position in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 55 shares during the period. Trifecta Capital Advisors LLC raised its stake in CME Group by 59.2% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 42 shares in the last quarter. Finally, Ransom Advisory Ltd acquired a new stake in CME Group in the 1st quarter worth about $31,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Up 1.3%

Shares of CME opened at $271.42 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $220.41 and a 52-week high of $290.79. The firm has a market cap of $97.87 billion, a price-to-earnings ratio of 26.30, a PEG ratio of 4.41 and a beta of 0.38. The business’s fifty day moving average is $265.66 and its 200-day moving average is $272.18.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the prior year, the company earned $2.68 EPS. CME Group’s revenue for the quarter was down 3.0% on a year-over-year basis. Equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date is Friday, December 12th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Insider Activity at CME Group

In related news, insider Timothy Francis Mccourt sold 379 shares of the company’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This represents a 3.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William R. Shepard acquired 262 shares of the company’s stock in a transaction that occurred on Thursday, September 25th. The stock was bought at an average cost of $265.19 per share, with a total value of $69,479.78. Following the purchase, the director owned 258,459 shares in the company, valued at $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders sold a total of 14,043 shares of company stock worth $3,791,486 in the last ninety days. Insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Keefe, Bruyette & Woods increased their target price on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research report on Monday, October 13th. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and increased their price target for the stock from $275.00 to $300.00 in a research report on Thursday, September 25th. Morgan Stanley lifted their price objective on CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. Barclays cut their target price on CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. raised their price target on CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 14th. Eight investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $285.19.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.